Overview

Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The aim of this current study was to assess the therapeutic effects of perindopril and telmisartan for hypertensive patients with NAFLD and make comparison between the therapeutic effects of these two kind of drugs. This study is a randomized parallel control clinical trial which would be carried out in Nanfang Hospital, Southern Medical University. About one hundred and eighty patients would be randomly assigned to perindopril,telmisartan and amlodipine three groups.
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Treatments:
Amlodipine
Perindopril
Telmisartan